EGFR and lung carcinoma: In addition, KDM5A is necessary to create a transient chromatin state in EGFR-mutant lung cancer cell lines with elevated expression driven by the IGF-1 signalling pathway in both DTPs and drug-tolerant expanded persisters (DTEPs).